 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/03/2026 |
$25.55 |
$26.25 |
$24.67 |
$25.91 |
1.29M | | 08/04/2026 |
$26.73 |
$28.42 |
$26.42 |
$28.35 |
2.15M | | 08/05/2026 |
$28.42 |
$28.47 |
$26.62 |
$27.07 |
2.06M | | 08/06/2026 |
$26.71 |
$27.99 |
$26.56 |
$27.25 |
1.17M | | 08/07/2026 |
$27.71 |
$28.35 |
$27.13 |
$27.48 |
1.32M |
 |
| Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. Co.'s suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. | |
 |

Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on August 03, 2026, BEAM opened at $25.55, traded as high as $26.25 and as low as $24.67, and closed at $25.91. Trading volume was a total of 1.29M shares. On August 04, 2026, BEAM opened at $26.73, traded as high as $28.42 and as low as $26.42, and closed at $28.35. Trading volume was a total of 2.15M shares. On August 05, 2026, BEAM opened at $28.42, traded as high as $28.47 and as low as $26.62, and closed at $27.07. Trading volume was a total of 2.06M shares. On August 06, 2026, BEAM opened at $26.71, traded as high as $27.99 and as low as $26.56, and closed at $27.25. Trading volume was a total of 1.17M shares. On August 07, 2026, BEAM opened at $27.71, traded as high as $28.35 and as low as $27.13, and closed at $27.48. Trading volume was a total of 1.32M shares.
BEAM Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/07/2020 |
|
| End date: |
08/07/2026 |
|
| Start price/share: |
$20.62 |
|
| End price/share: |
$27.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
33.27% |
|
| Average Annual Total Return: |
4.52% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,328.15 |
|
| Years: |
6.50 |
|
|
 |
| Date |
Close |
| 08/03/2026 | $25.91 | | 08/04/2026 | $28.35 | | 08/05/2026 | $27.07 | | 08/06/2026 | $27.25 | | 08/07/2026 | $27.48 |
|
 |